2nd Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts. Rare diseases need innovative therapies
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F25%3A00143465" target="_blank" >RIV/00216224:14110/25:00143465 - isvavai.cz</a>
Result on the web
<a href="https://creatic.muni.cz/creatic/conferences/creatic-conference-2025" target="_blank" >https://creatic.muni.cz/creatic/conferences/creatic-conference-2025</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
2nd Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts. Rare diseases need innovative therapies
Original language description
The CREATIC conference brings together leading experts from academia, clinical settings and research institutions from across the European region to jointly address challenges in the field of advanced therapies and rare diseases. The importance of advanced therapy medicinal products (ATMPs) and their remarkable outcomes for patients is increasingly recognized within the European Union. The two-day CREATIC conference is divided into five thematic sections, focusing on supporting innovation in ATMPs through networking, navigating ATMP regulation and reimbursement, innovation in cellular and gene ATMP research and development, personalized medicine in rare diseases – from precision genomics to GMP manufacturing – and the translation of ATMPs from the laboratory to patients.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30230 - Other clinical medicine subjects
Result continuities
Project
<a href="/en/project/LM2023049" target="_blank" >LM2023049: Czech National Node of the European Clinical Research Infrastructures Network</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů